IGF-1 LR3 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The most common research dosage for IGF-1 LR3 is 20-100 mcg daily; conservative protocols use 20-40 mcg, administered once daily, typically post-workout via subcutaneous injection (intramuscular for localized effect). Typical cycles run 4-8 weeks maximum to prevent receptor desensitization and insulin resistance. With a half-life of 20-30 hours (vs. ~15 minutes for native IGF-1), timing matters for optimal results.
What Is IGF-1 LR3 and Why Does Dosing Matter?
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a Growth factor analog, IGF-1 receptor agonist. Synthetic analog of endogenous IGF-1 with arginine extension and leucine substitution increasing half-life 20-30x over native IGF-1. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.
The standard research dosage for IGF-1 LR3 has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.
What Is the Recommended IGF-1 LR3 Dosage?
The most widely used IGF-1 LR3 dosage is 20-100 mcg daily; conservative protocols use 20-40 mcg, administered once daily, typically post-workout via subcutaneous injection (intramuscular for localized effect).
Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of IGF-1 LR3 is 20-30 hours (vs. ~15 minutes for native IGF-1), which directly determines how often you need to dose to maintain stable blood levels.
For IGF-1 LR3 specifically, the 4-8 weeks maximum to prevent receptor desensitization and insulin resistance cycle length is standard. Longer isn't always better — Growth factor analog, IGF-1 receptor agonist compounds require cycling to maintain receptor sensitivity.
When Should You Dose IGF-1 LR3?
With a half-life of 20-30 hours (vs. ~15 minutes for native IGF-1), timing your IGF-1 LR3 administration affects peak blood levels. Most protocols call for once daily, typically post-workout.
For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.
Calculate Your IGF-1 LR3 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for IGF-1 LR3.
Open Calculator →How Do You Reconstitute IGF-1 LR3?
IGF-1 LR3 typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.
Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.
How Long Should a IGF-1 LR3 Cycle Last?
Standard IGF-1 LR3 cycles run 4-8 weeks maximum to prevent receptor desensitization and insulin resistance. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.
Well-characterized pharmacology with established dosing protocols. No major human RCTs beyond exploratory trials. Animal studies confirm dose-dependent muscle growth and recovery acceleration. Hypoglycemia documented as the dose-limiting toxicity.
What Side Effects Can Affect Dosing?
Hypoglycemia is the most critical risk (shakiness, sweating, confusion, potential loss of consciousness). Insulin resistance with prolonged use. Fluid retention, headaches, joint stiffness, carpal tunnel syndrome. Theoretical cancer risk through mitogenic effects at supraphysiological doses. Acromegalic changes possible with chronic abuse.
If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most IGF-1 LR3-related side effects are dose-dependent.
How Does IGF-1 LR3 Dosing Change When Stacking?
Pairs with GHRP-2/6 or Hexarelin for synergistic anabolism. Often stacked with insulin post-workout to manage hypoglycemia risk. Requires glucose monitoring and careful food timing.
When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.
What Is the Bottom Line on IGF-1 LR3 Dosing?
Start at 20, dose once daily, typically post-workout, and run cycles of 4-8 weeks maximum to prevent receptor desensitization and insulin resistance. Monitor your response and adjust within the established range.
Source matters — always use research-grade IGF-1 LR3 from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.
Complete Guide
IGF-1 LR3 : Dosing, Mechanisms & Research
Related Reading
- IGF-1 LR3 Benefits
- IGF-1 LR3 Side Effects
- IGF-1 LR3 Stacking Guide
- IGF-1 LR3 Cycle Guide
- IGF-1 LR3 Research
- GHRP-2 Complete Guide
Research-Grade Sourcing
If you're going to research IGF-1 LR3, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is IGF-1 LR3?
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a Growth factor analog, IGF-1 receptor agonist. Synthetic analog of endogenous IGF-1 with arginine extension and leucine substitution increasing half-life 20-30x over native IGF-1. It is researched for rapid muscle growth, accelerated recovery, bone density increase, tendon healing, neurological protection, localized anabolic effect at injection site.
What is the recommended IGF-1 LR3 dosage?
Common dosages: 20-100 mcg daily; conservative protocols use 20-40 mcg administered once daily, typically post-workout via subcutaneous injection (intramuscular for localized effect). Cycle length: 4-8 weeks maximum to prevent receptor desensitization and insulin resistance. Half-life: 20-30 hours (vs. ~15 minutes for native IGF-1). Use our peptide calculator for exact reconstitution math.
What are the side effects of IGF-1 LR3?
Hypoglycemia is the most critical risk (shakiness, sweating, confusion, potential loss of consciousness). Insulin resistance with prolonged use. Fluid retention, headaches, joint stiffness, carpal tunnel syndrome. Theoretical cancer risk through mitogenic effects at supraphysiological doses. Acromegalic changes possible with chronic abuse.
Is IGF-1 LR3 safe?
IGF-1 LR3 has shown a preliminary safety profile in research. Not FDA-approved. WADA prohibited at all times with no Therapeutic Use Exemption pathway. Classified as research reagent. All research should follow appropriate safety protocols.